Management of immunosuppressive therapy in liver transplant recipients who develop bloodstream infection.

Michele BartolettiGiacomo VandiFrancesca FuriiValentina BertuzzoSimone AmbrettiSara TedeschiRenato PascaleFrancesco CristiniCaterina CampoliMaria Cristina MorelliMatteo CesconAntonio Daniele PinnaPierluigi VialeMaddalena Giannella

Published in: Transplant infectious disease : an official journal of the Transplantation Society (2018)

Any reduction in the immunosuppressive therapy was common and was associated with worse outcome in LT recipients developing BSI.

Keyphrases

stem cells
escherichia coli
gram negative
klebsiella pneumoniae
kidney transplantation